ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

MRI Network Sought By AACI Nearing Implementation

June 28, 1985

Surgeons Feel Cooperative Groups Discriminate Against Them, Ask For Better Deals From CCIRC

March 11, 1977

FCRC Decision Due In 90 Days, Upton Says

November 24, 1978

ASCO Calls For New Clinical Study Section, Endorses NCAB Action In Senate Testimony

July 23, 1993

Centers, Control to Be In New Division; Upton Moves Fink Up; Terry Acting Director Of DCCR

May 4, 1979

A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies

October 2, 2009